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Accumulation of T follicular helper (Tfh) cells and
proinflammatory cytokines drive autoantibody-medi-
ated diseases. The RNA-binding protein Roquin-1
(Rc3h1) represses the inducible costimulator ICOS
and interferon-g (IFN-g) in T cells to prevent Tfh cell
accumulation. Unlike Rc3h1san mice with a mutation
in the ROQdomain of Roquin-1, mice lacking the pro-
tein, paradoxically do not display increased Tfh cells.
Herewehave analyzedmicewithmutations that elim-
inate the RING domain from Roquin-1 or its paralog,
Roquin-2 (Rc3h2). RING or ROQ mutations both dis-
rupted IcosmRNA regulation byRoquin-1, but, unlike
the ROQ mutant that still occupied mRNA-regulating
stress granules, RING-deficient Roquin-1 failed to
localize to stress granules and allowed Roquin-2 to
compensate in the repression of ICOS and Tfh cells.
These paralogs also targeted tumor necrosis factor
(TNF) in nonlymphoid cells, ameliorating autoanti-
body-induced arthritis. The Roquin family emerges
as a posttranscriptional brake in the adaptive and
innate phases of antibody responses.
INTRODUCTION
Roquin-1 is a RING (really interesting new gene)-domain con-
taining protein encoded by the Rc3h1 gene with an important
function in controlling T follicular helper (Tfh) cells. It was discov-
ered and revealed as a crucial regulator of self-tolerance when
homozygosity for the Rc3h1 ‘‘san’’ allele in mice, which causes
an M199R amino acid substitution within a unique ROQ domain
of the protein, was found to segregate with excessive formation
of Tfh cells, spontaneous autoantibody production, and end-or-
gan pathology typical of lupus (Vinuesa et al., 2005). Roquin-1 is
expressed ubiquitously, but little is known about its other cellular
actions, including those within the innate immune system.Roquin-1 binds messenger RNA (mRNA) targets such as Icos
promoting their decay through the ROQ domain and an adjacent
CCCH-type zinc finger (Athanasopoulos et al., 2010; Chang
et al., 2012; Glasmacher et al., 2010; Yu et al., 2007). Consistent
with this function, Roquin-1 localizes to cytoplasmic stress gran-
ules (SGs) and processing (P) bodies, forming part of the mRNA
decapping complex within P bodies through its ability to interact
with RCK and the enhancer of decapping EDC4 (Glasmacher
et al., 2010). In Rc3h1san/san mice, the mutant protein fails to
repress target mRNAs, leading to overexpression of the T cell
inducible costimulator (ICOS) and interferon-g (IFN-g) (Lee
et al., 2012; Yu et al., 2007). Both of these molecules contribute
to the accumulation of Tfh cells that sustain and aberrantly select
germinal center (GC) B cells and cause autoimmunity (Lee et al.,
2012; Linterman et al., 2009; Yu et al., 2007).
Unlike Rc3h1san/san mice, Rc3h1-null mice showed no accu-
mulation of effector CD4+ T cells or Tfh cells (Bertossi et al.,
2011), suggesting the possibility of the existence of a related pro-
tein with redundant functions. A family of Rc3h1-like genes and
proteins can be traced in evolution from mammals to inverte-
brates. While C. elegans and D. melanogaster have a single
ancestral gene, in humans and mice there is one clear Roquin-1
paralog, Roquin-2 (also known asMNAB,membrane-associated
nucleic acid binding protein [Siess et al., 2000]). Roquin-2 is
encoded by the Rc3h2 gene. The two paralogs—Roquin-1 and
Roquin-2—appear to have arisen by ancient gene duplication
and lie on different chromosomes. The N termini of Roquin-1
and Roquin-2 share high-sequence similarity across the RING,
ROQ, and CCCH (C3H) domains (Figure 1A). Although the func-
tion of Roquin-2 remains unknown, both Roquin-1 and Roquin-2
are expressed ubiquitously and localize to RNA-regulating SGs
(Athanasopoulos et al., 2010). If the function of Roquin-1 can
be shared by another protein, Roquin-2 is an obvious candidate.
Here we set out to investigate the function of Roquin-2
and possible functional redundancies between Roquin-1 and
Roquin-2 by analyzing single- and double-RING mutant mice.
The experiments reveal that these paralogs share overlapping
mRNA targets and Roquin-2 can compensate for Roquin-1’s
RNA repression activity when Roquin-1 is not localized in SGs.
These results also identify anti-inflammatory effects of theImmunity 38, 669–680, April 18, 2013 ª2013 Elsevier Inc. 669
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Figure 1. Roquin-2 Localizes to SGs and P
Bodies and Represses Icos mRNA
(A) Schematic diagram of Roquin-1 and Roquin-2
proteins and amino acid sequence similarity for
each domain.
(B and C) HEK293T cells were transfected with
V5-RC3H2WT (shown in green), treated with 1 mM
sodium arsenite for 1 hr to induce SG formation,
and then fixed and stained with anti-eIF3 (B) or
anti-DCP1A (C) antibody (red). DNA is stained with
4’,6-diamidino-2-phenylindole (blue). Images in (B)
and (C) were all taken at the same magnification,
and the scale bar represents 50 mm.
(D) Retroviral vectors used to investigate full-
length (FL) IcosmRNA (including coding sequence
[CDS] and 30UTR) and Icos CDS repression by
Roquin-1 and Roquin-2. LTR, long terminal re-
peats; J, retroviral packaging element; HuCD4,
human CD4 protein; GFP, green fluorescent pro-
tein; IRES, internal ribosome entry site.
(E) Flow cytometric analysis of NIH 3T3 cells
following retroviral cotransduction of Rc3h1 (left
panel) or RC3H2 (right panel) with either Icos FL
mRNA (top panel) or Icos CDS mRNA (bottom
panel). Expression of Roquin-1 or Roquin-2 is
assessed by GFP fluorescence, whereas that of
ICOS is assessedbyhumanCD4 (HuCD4) reporter.
(F) Quantification of HuCD4 (normalized to empty
vector) on NIH 3T3 cells cotransduced with Icos
FL mRNA and either Rc3h1 or RC3H2.
(G) Similar to (F), but NIH 3T3 cells were cotrans-
duced with RC3H2 and either Icos FL mRNA or
Icos CDS mRNA. The vertical axes in (F) and (G)
show the fold difference in HuCD4 expression on
NIH 3T3 cells transduced with either Rc3h1 or
RC3H2 relative to empty vector. The dashed lines
in (F) and (G) indicate full (unrepressed) expression
of HuCD4. Data are representative of three inde-
pendent experiments. See also Figure S1.
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Roquin-1 and Roquin-2 Control Tfh and Inflammationproducts of these gene paralogs in nonlymphoid cells and estab-
lish a central role for the RC3H family as regulators of Tfh cell
homeostasis and inflammatory disease.
RESULTS
Roquin-2 Localizes to Stress Granules and Represses
Icos mRNA
Given the striking sequence similarity between Roquin-1 and
Roquin-2 (Figure 1A), we hypothesized that they might have
similar functions. Because Roquin-1 localizes to cytoplasmic670 Immunity 38, 669–680, April 18, 2013 ª2013 Elsevier Inc.SGs and P bodies, we tested whether
Roquin-2 could also be found in these
subcellular compartments. A comple-
mentary DNA (cDNA) encoding Roquin-2
was fused to a V5 tag and introduced
into HEK293T cells. Staining cells for
the SG and P-body markers eIF3 and
DCP1A, respectively, revealed that
Roquin-2 localized within both SGs (Fig-
ure 1B) and P bodies (Figure 1C) upon
arsenite treatment.We next asked whether Roquin-2 could repress IcosmRNA, a
target of Roquin-1. Roquin-2 and Roquin-1 were expressed in
NIH 3T3 cells using pR-IRES-GFP retroviral vectors, together
with a pR-IRES-CD4 retroviral vector expressing either full-
length (FL) Icos or only the coding region sequence (CDS), thus
lacking the 30UTR sequences recognized by Roquin-1 (Fig-
ure 1D). In this system, cell to cell differences in Roquin-1 and
Roquin-2 expression are inferred from differences in GFP fluo-
rescence, since they are encoded by a single bicistronic
mRNA, and human CD4 (HuCD4) fluorescence is an indicator
of Icos mRNA expression within individual cells. When NIH 3T3
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Figure 2. Generation and Phenotype of
Roquin-2 RING-Deficient Mice
(A) Generation of Roquin-2 ringless mice with a
deletion ofRc3h2 exon 2when crossed toRosa26-
cre transgenic strain. White boxes, noncoding
exons; black boxes, protein encoding exons;
NeoR, Neomycin resistance cassette.
(B and C) Deletion of Rc3h2 exon 2 detected in
MEFs by PCR (B) and sequencing (C) from cDNA.
Position of primers used for the PCR in (B) is
indicated as arrowheads in (A). M, DNA marker;
bp, base pairs; +/+, Rc3h2+/+; rin/rin, Rc3h2rin/rin.
(D) Contour plots showing the gating strategy to
isolate naive (CD44lo), effector and memory
(CD44hi), and Treg (CD25
hi) cells gated on CD4+
T cells (left panel), Tfh (CXCR5hi PD-1hi) cells gated
on CD4+ T cells (middle panel), and GC B (CD95+
GL-7+) cells gated on B220+ cells (right panel).
(E) ICOS mean fluorescence intensity (MFI) on
naive (CD44lo, left panel) or effector and memory
(CD44hi, right panel) CD4+ T cells from mice suffi-
cient (Rc3h2+/+) or deficient (Rc3h2rin/rin) in the
Roquin-2 RING domain.
(F) Proportions of effector and memory (CD44hi)
cells (left panel) and Tfh (CXCR5hi PD-1hi) cells
(middle panel) among total CD4+ T cells and of GC
B cells among total B220+ cells (right panel) in
Rc3h2+/+ and Rc3h2rin/rin mice. (E–F) Percentages
before (d0) and 6 days after SRBC immunization
(d6) are shown. ns, not significant. Each dot rep-
resents an individual mouse and bars represent
median values in each group. Data are represen-
tative of two independent experiments.
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Roquin-1 and Roquin-2 Control Tfh and Inflammationcells were cotransduced with RC3H2-IRES-GFP and Icos FL-
IRES-CD4, cells expressing high amounts of RC3H2-IRES-
GFP repressed HuCD4 expression by 50%, indicating that
Roquin-2 represses Icos 30UTRmRNA, albeit possibly to a lesser
extent than Roquin-1 (Figures 1E and 1F). As shown previously
for Roquin-1, Roquin-2 did not repress IcosmRNA in cells trans-
ducedwith Icos CDS-IRES-CD4 (Figures 1E and 1G), suggesting
that mRNA repression by Roquin-2 occurs via 30UTR targeting.
We considered the possibility that Roquin-1 and Roquin-2
form dimers or interact to jointly repress shared mRNA targets.
Reciprocal coimmunoprecipitation of Roquin-1-FLAG and V5-
Roquin-2 ectopically expressed in HEK293T cells failed to reveal
an interaction between Roquin-1 and Roquin-2 (see Figure S1
available online). Collectively, these data indicate that Roquin-2
and Roquin-1 have independent, overlapping ability to destabi-
lize Icos mRNA when their expression is enforced in vitro.
In Vivo Targeted Deletion of the Roquin-1 and Roquin-2
RING Domains
To compare the role of Roquin-1 and Roquin-2 as regulators of
mRNA decay in vivo, we used gene targeting in mice to produce
loss-of-functionmutations that eliminated the RINGdomain from
Roquin-1 or Roquin-2. The cre-LoxP methods were used to
ablate Rc3h2 exon 2, encoding the Roquin-2 translation start
site and RING domain, upon crosseswithRosa26-cre transgenic
mice to generate a germline deficiency (Figure 2A). This allele has
been designated Rc3h2rin. In the resulting Rc3h2rin mRNA, skip-ping of exon 2 resulted in a smaller transcript due to splicing of
exon 1 to exon 3 (Figures 2B and 2C), yielding an alternative
in-frame Kozak translation initiation site at Met130. Homozygous
Rc3h2rin/rin mice, which lacked the Roquin-2 RING domain in all
cell types, were viable and did not display ICOS overexpression
(Figures 2D and 2E). Enumeration of effector and memory CD4+,
Tfh, and GC B cells before or 6 days after sheep red blood cells
(SRBC) immunization did not reveal any differences with control
mice (Figures 2D and 2F).
The same strategy was used to produce mice with a germline
or T cell-specific deletion of Rc3h1 exon 2, which encodes the
Roquin-1 translation start codon and RING domain. Like the
Rc3h2rin allele, the resulting Rc3h1 ringless (Rc3h1rin) mRNA
also splices exon 1 to exon 3, yielding an alternative in-frame
Kozak translation initiation site at Met133 that produces an
N-terminally truncated protein. Homozygosity for the germline
Rc3h1rin results in perinatal lethality and a phenotype similar to
that described in mice lacking Rc3h1, with a lung inflation defect
and an incomplete closure of the neural tube (Figures 3A and 3B)
The phenotypic similarity between Rc3h1rin/rin and Rc3h1/
suggests that the Rc3h1rin allele results in a severe loss of func-
tion (Bertossi et al., 2011).
To circumvent perinatal lethality and investigate the conse-
quences of the Rc3h1rin mutation on ICOS regulation in T cells,
we generated mice with a T cell-specific deletion of Roquin-1
RING (Rc3h1flox/flox Lck-cre). As in mice lacking Rc3h1 (Bertossi
et al., 2011), there was no spontaneous accumulation of Tfh cellsImmunity 38, 669–680, April 18, 2013 ª2013 Elsevier Inc. 671
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Figure 3. Roquin-1 RING Deficiency Causes
Perinatal Mortality but Minimally Impairs
ICOS Repression
(A and B) Histological assessments of lung by
hematoxylin and eosin (H&E) staining (A) and
lumbar neural tube by Luxol Fast Blue-Cresyl
Violet (LFB-CV) staining (B) of embryos sufficient
(Rc3h1+/+) (left panel) or deficient (Rc3h1rin/rin)
(right panel) in the Roquin-1 RING at embryonic
day 19 (E19). Scale bar on the lung photomicro-
graph (A) represents 100 mm and that on the ver-
tebrae photomicrograph (B) represents 500 mm.
(C) ICOS MFI on naive (CD44lo) or effector and
memory (CD44hi) CD4+ T cells frommicewith T cell
conditional deletion of Rc3h1 RING (Rc3h1flox/flox
Lck-cre) or littermate controls (Rc3h1flox/+ Lck-cre
andRc3h1flox/flox) and frommice with the Roquin-1
M199R (ROQ) point mutation (Rc3h1san/san) or
littermate controls (Rc3h1san/+ and Rc3h1+/+).
Each dot represents an individual mouse and bars
represent the median value in each group. See
also Figure S2.
Immunity
Roquin-1 and Roquin-2 Control Tfh and Inflammationin Rc3h1flox/flox Lck-cre (Tringless) mice; GC B cell numbers were
comparable to those of Rc3h1flox/flox mice (data not shown).
ICOS expression on naive (CD44lo) and effector and memory
(CD44hi) CD4+ T cells was increased slightly in Roquin-1
Tringless mice similar to mice heterozygous for the Rc3h1san
allele analyzed in parallel (Figure 3C) butmuch less than in homo-
zygous Rc3h1san/san mice (Figure 3C).
Roquin-2 Compensates for RING-Deficient Roquin-1
We next tested the possibility that the apparent loss of function
of Roquin-1RINGLESS protein allowed its Icos-regulating function
to be compensated by wild-type (WT) Roquin-2 in Roquin-1
Tringlessmice. Supporting this hypothesis, Roquin-2 was found
to localize normally to SGs inRc3h1rin/rin mouse embryonic fibro-
blasts (Figures S2A and S2B). The RING domains were ablated
from both Roquin-1 and Roquin-2 in T cells by breeding Lck-
cre transgenic mice bearing homozygous Rc3h1flox/flox and
Rc3h2flox/flox alleles. Double Roquin-1 and Roquin-2 Tringless
mice (Rc3h1flox/flox Rc3h2flox/flox Lck-cre) had elevated ICOS
expression on effector and memory (CD44hi) CD4+ and Tfh
(CXCR5hi PD-1hi) cells compared to control Rc3h1flox/flox
Rc3h2flox/flox mice that did not inherit the Lck-cre transgene
or to their single Tringless counterparts (Figure 4A). This was
accompanied by increased IFN-g-producing cells and increased
formation of Tfh and GC B cells upon SRBC immunization (Fig-
ures 4A and 4B). Nevertheless, ICOS expression and Tfh and
GC B cell numbers were still higher in Rc3h1san/san mice than
in double Roquin-1 and Roquin-2 Tringless mice (Figure 4B).
Deletion of the RINGDomain Affects Localization to SGs
The data above suggest that Roquin-2 can compensate for
Roquin-1RINGLESS but not Roquin-1SAN mutations. There are
two possible interpretations for this difference. First, the ‘‘san’’672 Immunity 38, 669–680, April 18, 2013 ª2013 Elsevier Inc.missensemutation is either a neomorphic
or antimorphic allele, where the M199R
substitution results in a protein with novel
or dominant-negative activity. To testwhether the requirement for homozygosity of the Rc3h1san allele
was due to a gain-of-function or antimorphic effect that only
occurred with a double gene dosage of point mutant protein,
we compared mice that carried a single copy of the Rc3h1san
allele but carried, on the other chromosome, either a normal
Rc3h1 gene (san/+) or the loss-of-function Rc3h1rin allele
(san/rin). T cells in the resulting compound heterozygous
Rc3h1san/rin mice displayed increased CD44hi CD4+ and Tfh cells
and exaggerated ICOS expression on naive CD4+ cells compa-
rable to T cells from Rc3h1san/san mice with a double genetic
dose of the point mutant protein (Figure 4C). This result indicates
that the recessive ICOS dysregulation caused by Rc3h1san re-
flects a loss of Roquin-1’s RNA-regulating function.
The second interpretation for the inability of Roquin-2 to
compensate for Roquin-1SAN is that the ‘‘san’’ allele may act
recessively to encode a ‘‘niche-filling’’ protein, where assembly
into the mRNA regulating complex is preserved but the normal
mRNA-repressing function of Roquin-1 is lost. Previous evi-
dence has been presented that Roquin-1SAN localizes normally
to SGs (Athanasopoulos et al., 2010). Repression of mRNAs
such as Icos by Roquin-1 correlates with localization of the
protein to cytoplasmic P bodies, subcellular cytoplasmic com-
partments where 50-30 mRNA decay is thought largely to occur
(Glasmacher et al., 2010). P bodies and SGs have been shown
to be dynamically linked structures and their fusion promoted
and even stabilized by RNA-binding proteins such as TTP and
BRF1 (Kedersha et al., 2005). Localization of Roquin-1SAN in
the correct niche could then prevent compensatory substitution
by related proteins with overlapping functions. This type of
compensation for null but not missense alleles has previously
been demonstrated for the IKAROS protein family (Papathana-
siou et al., 2003). We therefore looked at the ability of an
N-terminal RING domain deleted Roquin-1 (Roquin-1133–1130;
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Figure 4. Partially Overlapping Functions of Roquin-1 and Roquin-2 in the Repression of Tfh Cell Activity and Inflammation
(A) Flow cytometric analysis on Lck-cre expressing double Rc3h1 and Rc3h2-floxed (Roquin-1 and Roquin-2 Tringless) mice and controls examined 6 days post-
SRBC immunization showing ICOS MFI on effector and memory (CD44hi) and Tfh (CXCR5hi PD-1hi) CD4+ T cells and proportions of Tfh cells among total CD4+
T cells and GC B among total B220+ cells. Control groups include double Roquin-1 and Roquin-2 floxed (Rc3h1flox/flox Rc3h2flox/flox), Rc3h2rin/rin (Roquin-2
ringless) and Rc3h1flox/flox Lck-cre (Roquin-1 Tringless) mice. *p% 0.05; **p% 0.01; ***p% 0.001. Data are representative of two independent experiments.
(B) Flow cytometric analysis on the double RING-domain mutant (Roquin-1 and Roquin-2 Tringless) mice and the Roquin-1 ROQ-domain mutant (Rc3h1san/san)
mice, showing ICOSMFI on Tfh (CXCR5hi PD-1hi) cells, proportions of IFN-g+ cells and Tfh (CXCR5hi PD-1hi) cells among total CD4+ T cells and proportions of GC
B cells among total B220+ cells. Percentages before (d0) and 6 days after SRBC immunization (d6) are shown.
(C) Proportions of effector and memory (CD44hi) cells (left panel) and Tfh (CXCR5hi PD-1hi) cells (middle panel) among total CD4+ T cells and ICOS MFI on naive
(CD44lo) or effector and memory (CD44hi) CD4+ T cells (right panel) from Rc3h1+/+, Rc3h1rin/+, Rc3h1san/+, Rc3h1san/rin, and Rc3h1san/san mice. Data are pooled
from two experiments. Each dot represents an individual mouse and bars represent the median value in each group.
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Roquin-1 and Roquin-2 Control Tfh and InflammationRoquin-1RINGLESS) to localize to P bodies and to SGs. When
ectopically expressed in HEK293T cells, V5-tagged Roquin-
1RINGLESS was still able to localize to P bodies, but only colocal-
ized with eIF3 (a SG marker) in 5% of arsenite-treated cells
compared to Roquin-1WT, which colocalized with eIF3 in 91%
of stressed cells (Figures 5A–5D). Additional tests using a
different marker for SG colocalization, TIA-1, confirmed that
Roquin-1RINGLESS localized outside of, but adjacent to, SGs (Fig-ures S3A–S3B’). Even though Roquin-2 still localized to SGs in
the presence of Roquin-1SAN (Figures S3C–S3E), the latter,
although not functional, is likely to retain its scaffold position
within RNA granules. Thus, unlike Roquin-1RINGLESS, Roquin-
1SAN may not create a void in the multimolecular RNA-regulating
assembly in SGs for Roquin-2 to occupy (Figure S3F).
Given our previous observation that GFP-tagged fragments of
Roquin-1 (138–337 or 138–484) that lacked both the RINGImmunity 38, 669–680, April 18, 2013 ª2013 Elsevier Inc. 673
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A Figure 5. Deficiency in the RING Domain
Causes Impaired SG Localization
(A and B) HEK293T cells transfected with V5-
Rc3h1WT (A) and V5-Rc3h1RINGLESS (B) were fixed
and costained with V5 antibody (green) and the
P body (PB) marker DCP1A (red).
(C–E) HEK293T cells were transfected with V5-
Rc3h1WT (C), V5-Rc3h1RINGLESS (D), or untagged
Rc3h1RINGLESS (E), treated with 1 mM sodium
arsenite for 1 hr to induce SG formation. Cells were
fixed and stained with eIF3 antibody (shown in red)
and either V5 antibody (green in C and D), or a
Roquin-1-specific antibody (green in E). Ectopi-
cally expressed V5-Rc3h1WT localizes to eIF3+
SGs (yellow arrowheads). White arrowheads show
V5-Rc3h1RINGLESS with impaired localization to
eIF3+ granules.
(F) HEK293T cells were transfected with V5-
RC3H2RINGLESS (stained with anti-V5, green),
treated with 1 mM sodium arsenite for 1 hr to
induce SG formation (+AS), then fixed and stained
with anti-eIF3 (shown in red).
(G) Nonstressed transfected cells were stained
with anti-DCP1A antibody (red). Images in (A)–(G)
were all taken at the same magnification, and the
scale bar represents 50 mm. Boxed inserts magnify
one particular region. DNA is stained with 4’,6-di-
amidino-2-phenylindole (blue). See also Figure S3.
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Roquin-1 and Roquin-2 Control Tfh and Inflammationdomain and the C-terminal half of the protein could localize to
SGs (Athanasopoulos et al., 2010), we investigated the pos-
sibility that the altered localization of the Roquin-1RINGLESS
(133–1130) mutant studied here was related to the tag. Retrovir-
ally expressed untagged Roquin-1RINGLESS (133–1130) also
failed to localize to SGs (Figure 5E) in HEK293T cells. Similar
to Roquin-1RINGLESS, the RING-deficient Roquin-2 protein
(Roquin-2RINGLESS) localized outside SGs upon stress induction
(Figure 5F) but retained its normal P-body localization (Fig-
ure 5G). These results conclusively demonstrate that the muta-674 Immunity 38, 669–680, April 18, 2013 ª2013 Elsevier Inc.tion engineered in the mice, which selec-
tively removes the RING domain from an
otherwise full-length protein, results in a
failure of the protein to localize to SGs.
Roquin-2 RING Deficiency
Exacerbates Roquin-1SAN Lethality
and Immune Pathology
In order to further understand the func-
tional overlap between the two Roquin
proteins and also test whether there are
any unique functions of Roquin-2, we
examined the effects of Roquin-2 RING
deficiency on the pathology caused
by homozygous Rc3h1san/san mutation.
Rc3h1san/san mice were crossed to
Rc3h2rin/rin mice to generate Rc3h1san/san
Rc3h2rin/rin mice and the relevant litter-
mate controls. Roquin-2 RING deficiency
caused premature and fully penetrant
mortality of Rc3h1san/san mice, with no
mice surviving beyond 22 weeks (Fig-ure 6A). Examination of the double-mutant mice revealed
elevated percentages of Tfh cells (Figure S4A) and more severe
inflammatory infiltrates in the kidney (Figure 6B) and other organs
(data not shown). Double mutant mice also exhibited increased
susceptibility to low-dose lipopolysaccharide (LPS): 2.5 mg/g
body weight LPS injection was lethal for 3 out of 4 double
mutants, but all single mutant controls survived; serum tumor
necrosis factor (TNF) in the surviving mouse 72 hr postinjec-
tion was 100-fold higher than in the controls (Figure S4B).
Similar susceptibility to LPS was also observed in irradiated
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Figure 6. RING Deficiency in Roquin-2 Causes Early Lethality and
Exacerbated Tissue Damage in Rc3h1san/san Mice
(A) Survival curve of weaned Rc3h1san/san Rc3h2rin/rin double-mutant mice and
control littermates with the indicated genotypes.
(B) H&E stains of kidneys from 13-week-old Rc3h1san/san (top panel) and
Rc3h1san/san Rc3h2rin/rin (bottom panel) mice. Arrows indicate tissue infiltrates.
Scale bar represents 100 mm. See also Figure S4.
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Roquin-1 and Roquin-2 Control Tfh and InflammationRag1/ recipient mice transplanted with Rc3h1san/san
Rc3h2rin/rin bone marrow: 1.2 mg/g body weight LPS was lethal
in 4 out of 5 mice, whereas mice in single mutant control groups
(Rc3h1san/san and Rc3h2rin/rin) remained healthy. These results
suggested that Roquin-1 and Roquin-2 control production of
proinflammatory cytokines.
Roquin-1 and Roquin-2 Act in Non-T Cells to Prevent
TNF-Dependent Immune Pathology
Lethality to LPS is mediated by secretion of proinflammatory
cytokines bymacrophages. We found elevated TNF in the serum
of Rc3h1san/san mice compared to control littermates, whereasinterleukin-1 (IL-1) was undetectable (Figure 7A; data not
shown). Given that the single ancestral Roquin gene is present
in C. elegans, and the appearance of the two paralogs only
occurs in jawed vertebrates after the appearance of adaptive
immunity, we considered the possibility the Roquin paralogs
may regulate innate immunity, specifically acting in myeloid cells
to regulate TNF-mediated immunity. To investigate the role of
Roquin-1 in nonlymphoid cells, we generated T and B cell-defi-
cient Rag1/ Rc3h1san/san and Rag1/ Rc3h1+/+ control
mice. Whereas lethality to high doses of LPS is primarily medi-
ated by secretion of IL-1 by macrophages (Ohlsson et al.,
1990), low doses of LPS combined with D-galactosamine treat-
ment cause lethal shock largely mediated by TNF because
Tnfrsf1a/ mice are resistant to this challenge (Peschon et al.,
1998). Whereas ten out of ten Rag1/ Rc3h1+/+ mice remained
unaffected, six out of eight Rag1/ Rc3h1san/san mice died from
endotoxic shock within 24 hr of low-dose LPS (5 pg/g) plus
20 mg D-galactosamine injection (Figure 7B).
We inferred from this finding that Roquin-1 and Roquin-2
might interact to regulate innate immunity and the inflammatory
response in autoimmunity (in addition to CD4+ T cell responses).
We investigated this further by using the K/BxN model of rheu-
matoid arthritis (Korganow et al., 1999; Matsumoto et al., 1999;
Solomon et al., 2005), modified by the elimination of T and B
cells. Joint inflammation in the K/BxN model is usually more
dependent on IL-1b than TNF (Ji et al., 2002), but arthritis in
Rag1/ Rc3h1san/san mice was accompanied by an exagger-
ated TNF response in lymph nodes draining arthritic joints (Fig-
ure 7C) and in macrophages isolated by peritoneal lavage; of
note, systemic amounts of TNF did not increase (Figure S5A).
Also, in contrast to the spontaneously elevated serum TNF
observed above in Rc3h1san/san mice with an intact T and B
cell repertoire, baseline serum TNF was comparable between
Rag1/ Rc3h1san/san and Rag1/ Rc3h1+/+ mice (Figure S5B).
Rag1/ Rc3h1san/san exhibited heightened susceptibility to
arthritogenic K/BxN serum compared to Rag1/ control mice
(Figure 7D). Furthermore, a serumdose (50 ml) that was subarthri-
togenic in most Rag1/ Rc3h1+/+ control mice induced severe
arthritis in Rag1/ Rc3h1san/san mice (Figure 7D). Synovial
inflammation induced by passive transfer of 200 ml K/BxN serum
was also more pronounced in the joints of Rag1/ Rc3h1san/san
mice (Figure S5C), which contained large numbers of F4/80+
macrophages (Figure S5D). There was a small increase in Il1b
mRNA (Figure 7C); nevertheless, TNF appears to account for
the heightened susceptibility to arthritis in this model because
the response serum in Rag1/ Rc3h1san/san was rendered
similar to that in Rag1/ mice by deletion of Tnf (Figure 7E).
After restimulation ex vivo with LPS, TNF production was 50-
fold higher per cell in cultures of macrophages from Rag1/
Rc3h1san/san mice compared to controls (Figures S5E and
S5F). This was not the result of an increased number of mye-
loid cells because the expansion of the myeloid cell compart-
ment seen in Rag1+/+ Rc3h1san/san (Vinuesa et al., 2005) mice
is corrected in Rag1/ Rc3h1san/san mice, and spleen cell
counts in mutant and control littermates are comparable
(Figure S5G). Collectively, these findings suggested that
Roquin-1SAN conferred an increased susceptibility to arthritis
due to an incremental effect of TNF to pathology normally
mediated by IL-1.Immunity 38, 669–680, April 18, 2013 ª2013 Elsevier Inc. 675
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Figure 7. Roquin-1 and Roquin-2 Repress TNF and TNF-Mediated Pathology
(A) Serum TNF assessed by flow cytometric bead array (BDBiosciences) fromRc3h1+/+ andRc3h1san/sanmice. Each dot represents an individual mouse and bars
represent the median value in each group. *p% 0.05.
(B) Survival curves for Rag1/ Rc3h1+/+ and Rag1/ Rc3h1san/san mice after injection of LPS (5 pg/g) plus 20 mg D-gal (n = 8 and 10 per group, respectively).
(C) Il1b and Tnf transcripts found in draining lymph nodes of Rag1/ Rc3h1+/+ and Rag1/ Rc3h1san/san mice 3 days after 50 ml K/BxN serum injection. Data
expressed relative to b-actin in unfractionated popliteal lymph nodes. a.u., arbitrary unit.
(legend continued on next page)
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Roquin-1 and Roquin-2 Control Tfh and InflammationIn order to test the proposition that Roquin-1 represses TNF
via a posttranscriptional mechanism similar to that described
for Icos mRNA, WT Roquin-1 (Roquin-1WT) and Roquin-1SAN
were expressed in NIH 3T3 cells by using the pR-IRES-GFP
retroviral vectors described in Figure 1D, together with a pR-
IRES-CD4 retroviral vector expressing the 30UTR of Tnf.
When NIH 3T3 cells were cotransduced with Rc3h1-IRES-GFP
and Tnf 30UTR-IRES-CD4, cells expressing high amounts of
Roquin-1 repressed HuCD4 expression by 25% (Figures 7F
and 7G), indicating that Roquin-1 represses Tnf 30UTR mRNA.
By contrast, cells transduced with Rc3h1san-IRES-GFP and
expressing high amounts of Roquin-1SAN displayed a significant
increase in HuCD4 expression (Figures 7F and 7G), consistent
with the hypothesis that Roquin-1SAN acts to promote Tnf
mRNA stability via its 30UTR.
To assess whether Roquin-2 has an independent role in regu-
lating TNF, we investigated production of this cytokine in
Rc3h2rin/rin mice, which have intact Roquin-1. Upon intraperito-
neal LPS (2.5 mg/g bodyweight) injection, therewas an increased
proportion of TNF-producing cells amongCD11b+macrophages
(Figure 7H). TNF expression within splenic CD11b+ cells was
also higher in Rc3h2rin/rin mice compared to WT littermates (Fig-
ure 7H). In addition, Roquin-2 ringless MEFs were cultured with
10 mg/ml LPS and TNF secretion was measured: lack of
Roquin-2 RING domain led to increased TNF production (Fig-
ure 7I). Roquin-2 ringless MEFs also expressed 3-fold higher
amounts of Tnf mRNA compared to controls (Figure 7I).
Roquin-1 and Roquin-2 also appeared to regulate TNF produc-
tion in CD4+ T cells because the proportion of TNF+ CD4+
T cells was increased in Rc3h1san/san mice and double Roquin-1
and Roquin-2 Tringless mice following low-dose LPS, but not
in single-mutant mice (Figure S5H). Together these results
suggest that Roquin-1 and Roquin-2 have partially but not
completely overlapping roles in TNF repression that are impor-
tant to dampen endotoxic shock and autoantibody-dependent
arthritis.
DISCUSSION
The experiments above illuminate the function of Roquin-1 and
Roquin-2, showing that these evolutionarily paralogous proteins
act in concert to dampen key mRNAs controlling inflammation(D) Arthritis clinical score of Rag1/ Rc3h1+/+ and Rag1/ Rc3h1san/san after inje
were performed by using four or five mice per group for each dose. Data are repre
score, and error bar represents SD; *p% 0.05.
(E) Arthritis clinical score in Rag1/ Rc3h1+/+, Rag1/ Rc3h1san/san, and Ra
Experiments were performed by using four and five mice per group. Each dot re
(F) Flow cytometric analysis of NIH 3T3 cells following retroviral cotransduction o
Roquin-1 is assessed by GFP fluorescence, whereas that of Tnf 30UTR is assess
(G) Quantification of human CD4 (HuCD4) reporter (normalized to empty vector)
vertical axis shows the fold difference in HuCD4 expression on NIH 3T3 cells tra
representative of three independent experiments. Each column represents the m
(H) Representative plots of mock PBS- (left top panel) and LPS-injected (bottom
among total splenic CD11b+macrophages (middle panel) and TNFMFI on CD11b
weight LPS injection. Splenocytes were restimulated ex vivo with 100 ng/mL LPS
represents an individual mouse, and bars represent median values in each group
(I) TNF production by Rc3h2+/+ or Rc3h2rin/rin MEFs after 16 hr culture with 10 mg
biological replicate, and columns represent median. ***p% 0.001. Data are repre
to b-actin) aremeasured by quantitative RT-PCR (right panel). Each column repres
0.001. a.u., arbitrary unit. See also Figure S5.and autoimmunity, including a known Roquin-1 target Icos and
an additional target, Tnf. Both Roquin proteins localize to
mRNA-regulating SGs and P bodies in the cytoplasm, and
both repressed Icos mRNA in a 30UTR-dependent fashion in
overexpression studies. The RING domain of both proteins is
shown here to be critical for their localization to SGs and their
function. In the absence of its RING domain, Roquin-1RINGLESS
protein behaved like a complete loss-of-function allele in causing
perinatal lethality and vertebral malformations. Roquin-1RINGLESS
protein was also unable to complement the ROQ M199R point
mutant protein to regulate Icos mRNA in T cells of compound
heterozygous Rc3h1san/rin mice. These in vivo results confirm
overexpression data of Glasmacher et al. (2010) that showed a
Roquin-1 construct lacking the RING domain had impaired
ability to repress Icos mRNA in vitro, and establish that the
ROQ M199R point mutation in the Rc3h1san mice is also a
loss-of-function allele with respect to Icos repression. WT
Roquin-2, but not the Rc3h2ringless allele, was able to compen-
sate for loss of RING domain from Roquin-1 to control Icos
mRNA in T cells. Loss of the RING domain from Roquin-2 on
its own, exaggerated Tnf mRNA accumulation in response to
LPS, and cooperated with the Roquin-1 M199R mutant to
increase proinflammatory cytokines, organ inflammation, and
mortality.
Our results provide evidence for overlapping functions of the
two proteins because the phenotypes conferred by defects in
Roquin-1 can be amplified by defects in Roquin-2. Because
the Rc3h1ringless mutation behaves like a Roquin-1 null allele
with respect to perinatal lethality and pathology, this poses two
key questions: (1) Why doesRc3h1ringless cause so little dysregu-
lation of ICOS or Tfh cells compared to the Rc3h1san mutation,
and (2) Why does the Rc3h1san mutation not cause perinatal
lethality? Analysis of compound heterozygous Rc3h1san/rin
mice revealed pronounced dysregulation of ICOS and CD4+
T cells, indicating that the RING and ROQ domain mutations
each disrupt Icos mRNA repression. The two mutations never-
theless differ in their effects on SG localization, because this
step is disrupted by the RING domain mutation but not the
ROQ domain point mutation. The Roquin-1RINGLESS mutant
protein, but not the Roquin-1SAN protein, vacates its sub-
cellular niche within SGs; however, both proteins still localize
to P bodies. As shown here, Icos repression is preserved inction with 200 ml (left panel) or 50 ml (right panel) of K/BxN serum. Experiments
sentative of two independent experiments. Each dot represents mean arthritis
g1/ Rc3h1san/san Tnf/ mice after transfer of 200 ml arthritogenic serum.
presents mean arthritis score, and error bar represents SD.
f Rc3h1WT (left panel) or Rc3h1SAN (right panel) with Tnf 30UTR. Expression of
ed by human CD4 reporter.
on NIH 3T3 cells transduced with Rc3h1WT or Rc3h1SAN with Tnf 30UTR. The
nsduced with either Rc3h1WT or Rc3h1SAN relative to empty vector. Data are
ean of three replicates, and error bars represent SD. *p% 0.05; **p% 0.01.
left panel) mice showing TNF and CD11b staining and proportion of TNF+ cells
+ cells (right panel) fromRc3h2+/+ andRc3h2rin/rin mice 48 hr after 2.5 mg/g body
in the presence of GolgiStop for 4 hr prior to intracellular TNF staining. Each dot
. *p% 0.05.
/mL LPS (measured in culture supernatants; left panel). Each dot represents a
sentative of three independent experiments. TnfmRNA transcripts (normalized
ents themean of three technical replicates, and error bars represent SD. ***p%
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Roquin-1 and Roquin-2 Control Tfh and InflammationRc3h1ringless T cells provided that there is normal Roquin-2, but
this is impaired when the RING domain of Roquin-2 is also
mutated. Hence the simplest explanation for the loss of Icos
repression caused by the Rc3h1san mutation, despite the pres-
ence of normal Roquin-2 in SGs, is that the ROQ-domain mutant
protein still occupies its niche within these subcellular compart-
ments and blocks the opportunity for functional compensation
by Roquin-2. Similar differences between recessive null mutants
and niche-filling loss-of-function point mutants have been
described for other proteins that are members of potentially
redundant families of paralogs, such as theMAP kinases in yeast
(Madhani et al., 1997) and the IKAROS transcription factor family
in mice (Papathanasiou et al., 2003).
In this study, both tagged and untagged full-length Roquin-1
protein failed to localize normally to SGs, defined either by
eIF3 or TIA-1 markers, when the RING domain was selectively
eliminated. Because the RINGLESS mutation has very similar
in vivo consequences to complete loss of the Roquin-1 protein,
the defect in SG localization is a clear and important finding of
the current study because it demonstrates a striking correlation
between Roquin-1 function and localization. As discussed
above, it may explain why the Roquin-1RINGLESS mutant is
more effectively compensated by Roquin-2 than the Roquin-
1SAN mutant. It is interesting to compare the failure of the
RINGLESS (133-1130) protein to localize to SGs with our earlier
finding that fragments of Roquin-1 (138-337 or 138-484) that
lacked both the RING domain and the C-terminal half of the
protein could localize to SGs. This suggests that SG localiza-
tion driven by the ROQ-CCCH domains is regulated by interplay
between the N-terminal RING domain and the C-terminal
domains that contain numerous potential sites for protein-pro-
tein interaction.
It is possible that the inability of Roquin-1RINGLESS to localize to
SGs is not in itself the direct cause of failed ICOS repression,
given that Icos mRNA is found in SGs and also in P bodies (Yu
et al., 2007) and Icos mRNA decay occurs in P bodies (Glas-
macher et al., 2010). Indeed, Roquin-1RINGLESS was found in P
bodies when overexpressed in HEK293T cells. Instead, failure
to localize to SGs may simply be an indicator of a severe func-
tional defect in the protein. It is also possible that RNA-regulating
processes in P bodies may be perturbed following defects in
RNA-sorting pathways including impaired shuttling of RNA-
binding proteins between SGs and P bodies.
ICOS expression, Tfh, and GC B cell numbers were still higher
in Rc3h1san/san mice than in double Roquin-1 and Roquin-2
Tringless mice. There are several nonmutually exclusive expla-
nations for this observation. First, it is possible that either one
or both the RING mutant proteins have not completely lost the
RNA-regulating activity; this is particularly plausible in the case
of Roquin-2 given the reported early lethality of Rc3h2/ mice
(V. Heissmeyer, personal communication), which differs from
our Rc3h2rin/rin mice that are viable and healthy. Second, the
ROQ mutant’s actions in nonlymphoid cells, such as those in
myeloid cells shown here, may exacerbate the T and B cell phe-
notypes. It is also possible that, at least in the regulation of some
targets, Roquin-1SAN exerts antimorphic effects—i.e., new or
interfering activities that do not reflect the normal function of
Roquin-1. Although this was not obvious in the case of ICOS
regulation, Roquin-1SAN appeared to aberrantly stabilize Tnf678 Immunity 38, 669–680, April 18, 2013 ª2013 Elsevier Inc.mRNA. In support of this hypothesis, we have shown previously
that Roquin-1SAN binds Icos mRNA with 3-fold higher affinity
than Roquin-1WT in vitro (Athanasopoulos et al., 2010). Finally,
the absence of perinatal lethality or vertebral malformation in
Rc3h1san/san homozygotes indicates that the ROQ domain
mutation disrupts Icos (and Tnf) repression but preserves an
apparently independent Roquin-1 activity in embryonic develop-
ment that requires the RING domain.
The experiments here reveal that although Roquin-1 and
Roquin-2 share some functional redundancies, their activities
are not completely overlapping. This conclusion is based on
the exaggerated TNF production by Rc3h2rin/rin macrophages
and MEFs with normal Roquin-1 and the lethal inflammatory dis-
ease and LPS-induced shock when the Rc3h2ringless mutation
was combined with Rc3h1san/san. Roquin-1 and Roquin-2 may
play nonredundant roles either by acting on the same mRNA tar-
gets (for example, Tnf) in different cell types and/or by acting on
different mRNA targets within the same cell. In T cells, Roquin-1
plays the major role in the repression of ICOS based on the data
from Rc3h1san/rin compound heterozygous mice, and because a
subtle phenotype is already observed in mice lacking active
Roquin-1 (shown here for Roquin-1 Tringless mice and by Ber-
tossi et al. [2011], by using T cell conditional Rc3h1/ mice)
that is not fully compensated by Roquin-2. Roquin-1 also facili-
tates perinatal survival in a manner dependent on the RING
domain, which cannot be either compensated by Roquin-2.
These differences between Roquin-1 and Roquin-2 are likely to
be mediated by their dissimilar C-termini that provide many sites
for protein-protein interaction.
This study provides evidence of a role for Roquin-1 in non-T
cells to alter the innate response to autoantibodies and bacterial
lipopolysaccharide (LPS). In the K/BxN model of rheumatoid
arthritis, immune complexes involving autoantibodies activate
macrophages, neutrophils, and mast cells to secrete IL-1b and
TNF, which trigger a cascade of events leading to joint destruc-
tion (Ji et al., 2002; Lee et al., 2002). We have shown that the
threshold for autoantibody-mediated arthritis is lowered as a
direct consequence of the effect of Roquin-1SAN onmyeloid cells
even in the absence of lymphocytes. This cell-intrinsic effect was
confirmed by demonstrating that homozygosity for the ‘‘san’’
allele of Rc3h1 accentuates septic shock as a result of TNF
secretion by macrophages: Rc3h1san/san mice succumbed to
sublethal doses of LPS in a septic shockmodel that is dependent
on TNF. Recent studies show an increasingly important contri-
bution of myeloid cells (mainly macrophages and neutrophils)
and TNF to lupus nephritis (Orme and Mohan, 2012; Saxena
et al., 2011). It is therefore likely that the severe kidney damage
in the Rc3h1san/san Rc3h2rin/rin mice is mediated by excessive
TNF production.
TnfmRNA decay has been known to be regulated by proteins
that localize in SGs and bind Tnf 30UTR (Carballo et al., 1998).
The data here add to evidence from TTP-deficient mice (Taylor
et al., 1996) and TNF transgenics that loss of strict posttranscrip-
tional control of TNF is sufficient to cause arthritis. The functional
hierarchy or relationship between Roquin-1, Roquin-2, and other
Tnf mRNA regulators such as TIA-1 and TTP still needs to be
elucidated. The RC3H family therefore emerges as a key player
of posttranscriptional regulation of adaptive humoral immunity
and the innate inflammatory response.
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Mice and Immunizations
Roquin-1 ringless and Roquin-2 ringless mice were generated by Ozgene,
LoxP sites that flanked or ‘‘floxed’’ Rc3h1/2 exon 2, encoding the start codon
and RING motif were introduced via homologous recombination in C57BL/6
mouse embryonic stem cells (ESCs). Recombinant ESC clones were im-
planted into foster mothers to yield chimeras. Heterozygote progeny were
screened for germline transmission before crossing toRosa26-Flp1mice to re-
move theNeoR cassette. Floxed Rc3h1 and Rc3h2 heterozygotes (Rc3h2flox/+)
were then crossed tomice expressing cre under the control of the endogenous
Rosa26 promoter. Removal of cre expression by backcrossing to C57BL/6
yielded germline deletions of Rc3h1/2 exon 2 (Roquin-1/Roquin-2 ringless
[rin allele]). C57BL/6 Tnf/ mice were made by H. Korner. Rc3h1san mice
were generated as previously described (Vinuesa et al., 2005). Mice were
housed under specific pathogen-free conditions. Where indicated, 8- to 12-
week-old mice were immunized intraperitoneally (i.p.) with 2 3 109 SRBC to
generate a GC response. To assess TNF production, we injected mice i.p.
with LPS, and spleens were harvested 48 hr postinjection. All experiments
were approved by the Australian National University Animal Ethics and Exper-
imentation Committee.
Plasmid Construction
To construct the N-terminal V5 tagged full-length Roquin-1, we PCR amplified
the cDNA from plasmid Roquin-GFP3 by using primers Roquin1F1: 50-
GGCTCTAGAATTCCGCAATGCCTGTACAAGCTCC-30 and SR-DownNotI:
50- CGCGAATGCGGCCGCCGGGAGCAGAATTGGAAACAAC-30. The ampli-
con was cloned into the EcoRI-NotI sites of the entry vector pENTR3C
(Invitrogen). This was recombined into the destination vector pcDNA3.1/
nV5-DEST (Invitrogen). The RINGLESS version of Roquin-1 was generated
by using site-directed mutagenesis (Quikchange, Agilent Technologies) to
create a second EcoRI site immediately upstream of the ATG codon at amino
acid position 133 (50- ACTACTCAGAGT GTTCTGGAATTCCCAATGCAGAG
GAAACTT-30) in the full-length Roquin-1 pENTR3C clone described above.
This construct was cut by using EcoRI to excise the RING domain region
and the vector religated. The resulting pENTR3C construct was recombined
into the destination vector pcDNA3.1/nV5-DEST (Invitrogen) generating V5-
Rc3h1RINGLESS. The untagged Roquin-1RINGLESS retroviral construct was con-
structed by cutting the Roquin-1RINGLESS pENTR3C vector SalI and EcoRV and
subcloned into the XhoI-blunted EcoRI sites of pKMV. The N-terminal V5-
tagged human RC3H2 cDNA was subcloned fromMNAB-GFP (Athanasopou-
los et al., 2010) as an XbaI-NotI fragment and cloned into the same sites of
pBluescriptII SK+. The fragment was excised using BamHI-NotI and cloned
into the same sites of pENTR2B before recombination into pcDNA3.1/nV5-
DEST by using the Gateway recombination system (Invitrogen). To construct
the C-terminal FLAG-tagged Roquin-1, we excised the cDNA from plasmid
Roquin-GFP (Athanasopoulos et al., 2010) and cloned it into the XbaI-NotI
sites of the vector pMZS3F (kind gift from J.F. Greenblatt, University of
Toronto).
Antibodies
Antibodies for immunofluorescence studies were as follows: DCP1A (gift from
J. Lykke-Andersen, University of California San Diego), eIF3 (Santa Cruz
Biotechnology), V5-tag (AbD Serotec), FLAG-tag (Sigma-Aldrich), rabbit anti-
seraagainstRoquin-2 (gift fromStevenHefeneider; OregonHealth andScience
University), andRoquin-1 (NovusBiologicals). Secondary antibodieswere con-
jugated to Alexa 568 or Alexa 488 (Molecular Probes, Invitrogen). Antibodies
for flow cytometric studies were as follows: mouse CD4, B220, CD11c,
CXCR5, CD25, GL-7, Fas (CD95), and human CD4 were purchased from BD
Biosciences; mouse CD11b and CD44 were purchased from BioLegend; and
mouse PD-1, ICOS, and TNF were purchased from eBioscience.
Flow Cytometry
Lymph nodes and spleen for myeloid cell population analysis were treatedwith
Collagenase P (Roche) and DNase I (Sigma-Aldrich) before preparing single-
cell suspensions. To stain for surface markers, we incubated cells in the anti-
body mixture diluted in ice-cold staining buffer (2% fetal calf serum [FCS] and
0.1% NaN3 in PBS). Intracellular TNF was stained by using the IntracellularStaining Kit (eBioscience). Cytokines in culture supernatants and serum
were measured by using CBA bead assays following the manufacturer’s in-
structions (BD Biosciences). A BD FACSCalibur and LSRII Flow Cytometer
with FACSDiva software were used for flow cytometry acquisition, and FlowJo
(Tree Star) was used for analysis.
In Vitro LPS Stimulation and Cytokine Measurements
For measurements of TNF from culture supernatants, peritoneal cells (53 105/
well) from mice injected 6 days previously with 100 ml of K/BxN serum were
stimulated with 1 mg/ml E. coli LPS (Sigma-Aldrich). Culture supernatants
were collected after a 5-day incubation period. Rc3h2rin/rin and Rc3h2+/+ fibro-
blasts were isolated from E14 embryos, cultured in DMEM medium supple-
mented with 10% FCS and antibiotics, and stimulated with 10 mg/ml LPS for
16 hr. The Mouse Inflammation Cytokine Bead Array kit (BD Biosciences)
was used to determine TNF concentrations. Intracellular TNF measurement
was performed after overnight stimulation with 100 ng/ml E. coli LPS.
Immunofluorescence
HEK293T cells were prepared for fluorescence microscopy as previously
described (Athanasopoulos et al., 2010). Images were collected by using
an Olympus IX71 microscope with DP Controller software (Olympus) and
compiled by using Adobe Photoshop software.
KBxN Serum-Induced Arthritis
C57BL/6 Rag1/ Rc3h1san/san or Rag1/ Rc3h1+/+ control littermates were
injected intravenously with pooled serum obtained from arthritic K/BxN
mice. Criteria for clinical scores were as follows: 0, normal; 1, mild swelling
of the dorsumof paw; 2, mild redness and swelling of one large joint or redness
and swelling limited to individual digits (any number of digits); 3, redness and
swelling of two large joints, or severe redness and swelling of entire paw
(including digits); 4, maximally inflamed limb with involvement of multiple
joints. Scores for each limb were added. Ankle thickness was measured
with an electronic calliper.
Endotoxic Shock Induction
Susceptibility to LPS plus D-galactosamine was examined by intravenously
(i.v.) injection of 20 mg D-galactosamine (Sigma-Aldrich) and 5 pg/g LPS
(Sigma-Aldrich) into Rag1/ Rc3h1san/san or Rag1/ Rc3h1+/+ controls.
This sublethal dose was selected after titration of susceptibility to LPS plus
D-gal in Rag1/ mice. Mice were closely monitored for any signs of septic
shock and sacrificed at 72 hr.
Retroviral Transductions
Packaging of retroviruses, virus titrations, transduction of NIH 3T3 cells, and
quantification of target mRNA expression relative to empty vector expression
have been described before (Vinuesa et al., 2005; Yu et al., 2007). The full-
length or CDS of Icos mRNA and 30UTR of Tnf mRNA (clone NM_013693.2)
were amplified by PCR and inserted into the pR-IRES-CD4 retroviral vector.
Rc3h1 and RC3H2 cDNA were also amplified and inserted into the pR-IRES-
GFP retroviral vector. Primer sequences are available on request. Retroviral
supernatants were harvested from packaging Phoenix cells transfected with
individual retroviral constructs. NIH 3T3 cells were transduced by retroviruses
via spinoculation.
Immunoprecipitation and Immunoblotting
Whole-cell lysates were prepared using TNE lysis buffer (1% NP-40, 150 mM
NaCl, 20mMTris-base, 1mMEDTA and Roche Complete EDTA-free protease
inhibitory cocktail tablet). To immunoprecipitate proteins, we added antibody
to precleared lysates, mixed them with Protein G Sepharose 4 Fast Flow (GE
Healthcare) for 12 hr, and then washed them. For immunoblotting, lysates
were separated by SDS-PAGE, transferred to nitrocellulose membrane,
blocked in 5% BSA Tris-buffered saline containing 0.05% Tween-20, probed
with primary antibodies, and detected with horseradish peroxidase-conju-
gated anti-rabbit secondary antibodies.
Histology
Tissues were fixed in 10% neutral buffered formalin and embedded in paraffin.
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Roquin-1 and Roquin-2 Control Tfh and Inflammation(LFB-CV) where indicated. For evaluation of arthritis, H&E staining was per-
formed on paraffin-embedded knee-joint sections taken 6 days after 200 ml
K/BxN serum transfer. The F4/80 antibody used in the immunohistochemical
staining of knee joint was purchased from BioLegend.
Quantitative PCR
Real-time PCR reactions were performed following standard protocols previ-
ously described (Vinuesa et al., 2005). In brief, RNA was isolated by using
TRIzol reagent (Invitrogen) and reverse-transcribed with oligo(dT) by using
Superscript II RT enzyme (Invitrogen). cDNA expression was determined
with the ABI Prism 7900 sequence detection system and Sybr-Green reagents
(Applied Biosystems). Primer sequences for Il1b and Tnf are available on
request. Fluorescence signals were measured over 40 PCR cycles and the
cycle (Ct) at which signals crossed a threshold set within the logarithmic phase
was recorded. TheCt for the target genewas subtracted from theCt for b-actin
(DCt). The relative amount of mRNA was calculated as 2DCt.
Statistical Analysis
Statistics were calculated by nonparametric Mann-Whitney test (U test) to
analyze two variable comparisons in flow cytometry experiments and when
assessing arthritis scores over time. Results from cell culture experiments
were analyzed by using unpaired Student’s t test. All statistical analysis was
performed with Prism software (GraphPad Software). Statistically significant
differences are indicated as * = p % 0.05, ** = p % 0.01, *** = p % 0.001,
and ns = not significant. Unless otherwise specified, each dot in graphs corre-
sponds to one biological replicate.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.immuni.2013.01.011.
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